268 related articles for article (PubMed ID: 34882298)
21. Abscopal effect following nivolumab induction in a patient with metastatic renal cell carcinoma-unique pathological features of the primary specimen: A case report.
Hori K; Hirohashi Y; Aoyagi T; Taniguchi N; Murakumo M; Miyata H; Torigoe T; Abe T; Shinohara N; Morita K
Exp Ther Med; 2020 Mar; 19(3):1903-1907. PubMed ID: 32104247
[TBL] [Abstract][Full Text] [Related]
22. Pancreatic metastasis of malignant melanoma presenting as a tumor occluding the main pancreatic duct.
Mizukoshi K; Matsumori T; Kurokawa K; Takeda H; Yamamoto S; Uza N; Seno H
Clin J Gastroenterol; 2022 Oct; 15(5):994-998. PubMed ID: 35727502
[TBL] [Abstract][Full Text] [Related]
23. Multimodal therapy with surgery and adjuvant nivolumab for late-onset multiple liver metastases of choroidal malignant melanoma: a case report.
Muraki R; Morita Y; Ida S; Kitajima R; Furuhashi S; Kiuchi R; Takeda M; Kikuchi H; Hiramatsu Y; Sakaguchi T; Kasuya A; Hotta Y; Takeuchi H
Surg Case Rep; 2020 Jul; 6(1):187. PubMed ID: 32737694
[TBL] [Abstract][Full Text] [Related]
24. Advanced esophagogastric junction cancer with brain, bone and gastric intramural metastases responding to combined modality therapy.
Takagi T; Kobayashi S; Sekimura A; Komaya K; Yamauchi Y; Hori A
J Rural Med; 2021 Jul; 16(3):179-183. PubMed ID: 34239632
[TBL] [Abstract][Full Text] [Related]
25. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
[No Abstract] [Full Text] [Related]
26. Immunotherapy against esophageal primary amelanotic malignant melanoma relapse.
Tsukamoto R; Ihara H; Takase M; Shimazu A; Takei M; Miura H; Sakamoto K; Namekata K
J Surg Case Rep; 2021 Oct; 2021(10):rjab393. PubMed ID: 34659737
[TBL] [Abstract][Full Text] [Related]
27. Primary malignant melanoma in gastroesophageal junction with 36 months' recurrence-free: a case report.
Dai Y; Zhang Y; Chen Y; Fan X; Lin H; Pan J
AME Case Rep; 2022; 6():22. PubMed ID: 35928577
[TBL] [Abstract][Full Text] [Related]
28. A first reported case of metastatic anorectal amelanotic melanoma with a marked response to anti-PD-1 antibody nivolumab: A case report.
Tokuhara K; Nakatani K; Tanimura H; Yoshioka K; Kiyohara T; Kon M
Int J Surg Case Rep; 2017; 31():188-192. PubMed ID: 28171845
[TBL] [Abstract][Full Text] [Related]
29. Analysis of the Abscopal Effect With Anti-PD1 Therapy in Patients With Metastatic Solid Tumors.
Ribeiro Gomes J; Schmerling RA; Haddad CK; Racy DJ; Ferrigno R; Gil E; Zanuncio P; Buzaid AC
J Immunother; 2016; 39(9):367-372. PubMed ID: 27741091
[TBL] [Abstract][Full Text] [Related]
30. Possible abscopal effect in urothelial carcinoma of the upper urinary tract after treatment with immune checkpoint inhibitors.
Ishiyama Y; Takagi T; Yoshida K; Iizuka J; Kakuta Y; Okumi M; Ishida H; Tanabe K
IJU Case Rep; 2020 Jan; 3(1):25-27. PubMed ID: 32743462
[TBL] [Abstract][Full Text] [Related]
31. Primary esophageal malignant melanoma successfully treated with anti-PD-1 antibody for retroperitoneal recurrence after esophagectomy: A case report.
Endo F; Akiyama Y; Onishi M; Fujisawa R; Sasaki N; Nikai H; Baba S; Sugimoto R; Kimura T; Takahara T; Iwaya T; Otsuka K; Nitta H; Koeda K; Sugai T; Sasaki A
Int J Surg Case Rep; 2020; 75():152-156. PubMed ID: 32950945
[TBL] [Abstract][Full Text] [Related]
32. A Case of Advanced Gastroesophageal Junction Cancer with Bulky Lymph Node Metastases Treated with Nivolumab.
Nakamura N; Kinami S; Fujita J; Kaida D; Tomita Y; Miyata T; Fujita H; Ueda N; Takamura H; Kosaka T
Case Rep Oncol; 2020; 13(2):702-707. PubMed ID: 32774260
[TBL] [Abstract][Full Text] [Related]
33. Serial pseudoprogression of metastatic malignant melanoma in a patient treated with nivolumab: a case report.
Ozaki Y; Shindoh J; Miura Y; Nakajima H; Oki R; Uchiyama M; Masuda J; Kinowaki K; Kondoh C; Tanabe Y; Tanaka T; Haruta S; Ueno M; Kitano S; Fujii T; Udagawa H; Takano T
BMC Cancer; 2017 Nov; 17(1):778. PubMed ID: 29162045
[TBL] [Abstract][Full Text] [Related]
34. Abscopal effect of radiation on lymph node metastasis in esophageal carcinoma: A case report and literature review.
Zhao X; Kang J; Zhao R
Oncol Lett; 2018 Sep; 16(3):3555-3560. PubMed ID: 30127961
[TBL] [Abstract][Full Text] [Related]
35. Primary esophageal malignant melanoma without recurrence after surgery and adjuvant therapy with nivolumab.
Nambara S; Sakaguchi Y; Tsuda Y; Kudou K; Kusumoto E; Yoshida R; Kusumoto T; Ikejiri K
Int Cancer Conf J; 2023 Apr; 12(2):100-103. PubMed ID: 36896199
[TBL] [Abstract][Full Text] [Related]
36. [A case of mixed adenoneuroendocrine carcinoma of the esophagogastric junction treated with neoadjuvant chemotherapy].
Nakai M; Kawasaki H; Wajima N; Kimura A; Nakayama Y; Muroya T; Yonaiyama S; Okano K; Nagase H; Hakamada K
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2301-3. PubMed ID: 24394092
[TBL] [Abstract][Full Text] [Related]
37. Abscopal Effects in Radio-Immunotherapy-Response Analysis of Metastatic Cancer Patients With Progressive Disease Under Anti-PD-1 Immune Checkpoint Inhibition.
Trommer M; Yeo SY; Persigehl T; Bunck A; Grüll H; Schlaak M; Theurich S; von Bergwelt-Baildon M; Morgenthaler J; Herter JM; Celik E; Marnitz S; Baues C
Front Pharmacol; 2019; 10():511. PubMed ID: 31156434
[TBL] [Abstract][Full Text] [Related]
38. Lymph node metastases of adenocarcinoma of the esophagus and esophagogastric junction.
Zhang X; Watson DI; Jamieson GG
Chin Med J (Engl); 2007 Dec; 120(24):2268-70. PubMed ID: 18167216
[TBL] [Abstract][Full Text] [Related]
39. Case report: A case of metastatic BRAFV600-mutated melanoma with heart failure treated with immune checkpoint inhibitors and BRAF/MEK inhibitors.
Nishizawa A; Kawakami M; Kitahara Y
Front Oncol; 2024; 14():1366532. PubMed ID: 38529375
[TBL] [Abstract][Full Text] [Related]
40. Abscopal effect of radiation therapy after nivolumab monotherapy in a patient with oral mucosal melanoma: A case report.
Igarashi H; Fukuda M; Konno Y; Takano H
Oral Oncol; 2020 Sep; 108():104919. PubMed ID: 32713809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
